Risks include mild gastrointestinal discomfort, headaches, injection site irritation, and unknown long-term effects
Theoretical concerns The limited human research on these peptides means some potential concerns remain theoretical: Cancer risk: Any peptide that promotes cell proliferation and blood vessel formation raises questions about potential effects on existing tumors
The Redefine 1 trial discovered that evaluation of the treatment effect of those treated with CagriSema reached weight loss upwards of 20.4%, from an average baseline body weight of 236 lb., at 68 weeks compared to 3.0%, from an average baseline body weight of 235 lb., for the placebo group which was statistically significant
Choosing between them requires understanding whether your research question demands receptor selectivity or multi-pathway integration
In some embodiments, the otic formulation or composition comprises about 0.06% by weight of the cholesterol
Investigations include effects on cortical BDNF expression, post-ischemic recovery, and protection against oxidative neuronal injury
